Archives
Parathyroid hormone (1-34) (human): Precision Tool for Bo...
Parathyroid hormone (1-34) (human): Precision Tool for Bone and Calcium Homeostasis Research
Executive Summary: Parathyroid hormone (1-34) (human) is a bioactive polypeptide fragment that functions as a potent parathyroid hormone 1 receptor (PTH1R) agonist, modulating calcium homeostasis and bone metabolism. Its IC50 for PTH1R binding is 2 nM, with a cAMP production IC50 of 0.22 nM in human kidney 293 cells (APExBIO product page). The peptide is highly soluble in DMSO (≥399.3 mg/mL) and water (≥19.88 mg/mL), but insoluble in ethanol. In vivo, repeated subcutaneous administration increases trabecular and cortical bone mass in rat models in a dose- and time-dependent manner (Huang et al., 2025). The product is intended strictly for research use and should be stored desiccated at -20°C.
Biological Rationale
Parathyroid hormone (1-34) (human), also known as PTH (1-34), is a synthetic peptide fragment corresponding to the N-terminal 34 amino acids of native human parathyroid hormone. This region retains full biological activity and receptor affinity (APExBIO). It is secreted endogenously by the chief cells of the parathyroid glands. PTH (1-34) plays a decisive role in regulating serum calcium by acting on bone, kidney, and, indirectly, the intestine. It is a vital research tool for dissecting calcium homeostasis and bone remodeling mechanisms, as well as for modeling osteoporosis, hypocalcemia, and related metabolic disorders (Amyloid.co article—this article provides updated, protocol-oriented insights).
Mechanism of Action of Parathyroid hormone (1-34) (human)
PTH (1-34) binds and activates the parathyroid hormone 1 receptor (PTH1R) and parathyroid hormone 2 receptor (PTH2R), both G protein-coupled receptors (GPCRs), to initiate cAMP and inositol phosphate signaling pathways (Huang et al., 2025). Upon receptor activation:
- Bone: Osteoblasts increase RANKL expression, promoting osteoclast differentiation and bone resorption, thereby elevating blood calcium.
- Kidney: Stimulates renal tubular reabsorption of calcium and magnesium; downregulates phosphate reabsorption.
- Intestine: Increases active vitamin D production, enhancing intestinal calcium absorption.
The peptide fragment’s effect on cAMP signaling is potent, with a reported IC50 of 0.22 nM in human kidney 293 cells expressing PTH1R (APExBIO). It also stimulates inositol phosphate synthesis at concentrations ≥24 nM.
Evidence & Benchmarks
- PTH (1-34) (human) binds human PTH1R with an IC50 of 2 nM, determined by receptor binding assays at 25°C in buffer pH 7.4 (APExBIO).
- cAMP accumulation in PTH1R-expressing HEK293 cells exhibits an IC50 of 0.22 nM, measured at 37°C over 30 minutes (APExBIO).
- PTH (1-34) stimulates inositol phosphate synthesis at ≥24 nM in human kidney 293 cells in vitro (APExBIO).
- Solubility: ≥399.3 mg/mL in DMSO and ≥19.88 mg/mL in water at room temperature; insoluble in ethanol (APExBIO).
- Subcutaneous administration (10 or 40 μg/kg/day, 4 weeks) in male Fisher 344 rats increases trabecular and cortical bone mass, assessed by µCT and histomorphometry (Huang et al., 2025).
- hPSC-derived kidney assembloids respond to PTH1R agonists with measurable modulation of calcium signaling, highlighting translational potential for disease modeling (Huang et al., 2025).
Compared to this mechanistic foundation analysis, the present article incorporates the latest quantitative data and workflow parameters for reproducible outcomes.
Applications, Limits & Misconceptions
PTH (1-34) (human) is a gold-standard tool for:
- Bone Metabolism Research: Modeling osteoblast and osteoclast dynamics, bone formation, and resorption.
- Osteoporosis Models: Inducing and monitoring bone anabolic responses in rodent models and in vitro cell systems.
- Calcium Homeostasis Studies: Quantitative assessment of serum and cellular calcium regulation.
- Kidney and Intestinal Calcium Handling: Investigating renal reabsorption and vitamin D–mediated intestinal absorption.
- Advanced Organoid and Assembloid Models: Modulating PTH1R/PTH2R signaling in human kidney assembloids for disease modeling (Huang et al., 2025).
For experimental integration strategies and troubleshooting, see this workflow optimization guide—this article updates those practices with recent quantitative solubility and storage data.
Common Pitfalls or Misconceptions
- Not a Full-Length Hormone: PTH (1-34) is a fragment; it lacks C-terminal regulatory domains and may not recapitulate all effects of endogenous parathyroid hormone.
- Research Use Only: The peptide is not intended for clinical or diagnostic use. No FDA/EMA approval for human therapy (APExBIO).
- Long-Term Storage in Solution: Stability is compromised in aqueous or DMSO solutions; prepare fresh aliquots for each experiment.
- Species-Specific Responses: Human PTH (1-34) may show reduced potency or altered pharmacokinetics in non-human species.
- Receptor Specificity: Does not distinguish between PTH1R and PTH2R in most cellular systems—interpret functional readouts accordingly.
Workflow Integration & Parameters
PTH (1-34) (human) (SKU A1129) from APExBIO is supplied as a lyophilized solid. For optimal performance:
- Reconstitution: Dissolve in DMSO (≥399.3 mg/mL) or water (≥19.88 mg/mL) at room temperature. Avoid ethanol.
- Aliquoting: Prepare single-use aliquots to avoid freeze-thaw cycles. Store desiccated at -20°C.
- Assay Concentrations: For cAMP or inositol phosphate signaling, use 0.1–100 nM in cell-based assays. For in vivo rodent studies, administer 10–40 μg/kg/day subcutaneously as per validated protocols.
- Timing: Use freshly prepared solutions; do not store reconstituted peptide for extended periods due to risk of degradation.
- Controls: Include vehicle and negative controls (buffer or DMSO only) for accurate interpretation.
For comparison with advanced cell and kidney models, this resource discusses unique signaling nuances; the current article expands on quantitative solubility and kinetic parameters.
Conclusion & Outlook
Parathyroid hormone (1-34) (human) is a robust, reproducible research reagent for probing calcium homeostasis, bone metabolism, and receptor-mediated signaling. Its quantitative benchmarks and solubility data underpin reliable experimental design across cell, tissue, and animal models. Recent advances in kidney assembloid and organoid systems further highlight its translational research value (Huang et al., 2025). For full details and ordering, refer to the APExBIO Parathyroid hormone (1-34) (human) product page.